Infiltration of the peripheral nervous system (PNS) by lymphoma, called neurolymphomatosis, is a rare condition among the spectrum of lymphoma-associated neuropathies; its diagnosis is challenging. Cerebrospinal fluid (CSF) analysis is of great value, but nerve biopsy (NB) may be necessary to prove invasion by malignant cells. Clonality polymerase chain reaction (PCR)-based analysis is a validated method in the diagnosis of hematological malignancies, but there are very little data on its diagnostic yield on NB samples. We explored the contribution of NB with clonality analysis to the diagnosis of neurolymphomatosis in 15 patients with negative CSF analysis. Moreover, we assessed the performance of clonality testing in a case-control manner, using patients with inflammatory infiltrates on NB as controls. Neurolymphomatosis was the first manifestation of lymphoma in 60% and could be diagnosed on routine histology alone in 40%. Clonality testing showed monoclonal rearrangement in 86.7% and was unsuccessful in 8.1%. Performance of clonality testing was as follows: 92.9% positive predictive value, 90% negative predictive value, 86.7% sensitivity, 94.7% specificity. This study confirms the diagnostic challenge of neurolymphomatosis, the usefulness of NB in patients with negative CSF analysis, and highlights the high yield of PCR-based clonality testing to assess the malignant nature of PNS lymphoid infiltrates.
INTRODUCTION
Neurolymphomatosis (NL), which is a rare and generally devastating condition, is defined by the infiltration of the peripheral nerves by neoplastic cells from a hematological malignancy. It is called secondary NL when it occurs during the course of one of these hematological conditions (i.e. when it is secondary to a systemic or to a primary central nervous system lymphoma), and primary NL when it reveals a nonHodgkin malignant lymphoma or leukemia consisting of isolated nervous involvement by lymphoma cells (1, 2) . NL can affect any part of the peripheral nervous system (PNS), including cranial nerves, roots, plexuses, and nerve trunks, leading to a wide range of presentations (3) (4) (5) (6) (7) (8) (9) . Its diagnosis is challenging and relies on imaging (10) , cerebrospinal fluid (CSF) cytology (1, 2) , and nerve tissue histology (9) . Indeed, nerve biopsy (NB) is helpful if CSF examination does not prove the presence of malignant cells (1, 9) . It can show the presence of cells that have cytological characteristics suggestive of malignancy, and the demonstration of a clonal population of lymphoid cells is theoretically of great value although it has not been systematically investigated given the few studies in which clonality has been evaluated on NB samples (11, 12) . Moreover, it has never been compared with a control group with nerve cellular infiltrates of nonlymphomatous origin. Therefore, we retrospectively investigated the diagnostic yield of polymerase chain reaction (PCR)-based assessment of clonality in frozen nerve tissue from patients with suspected NL and negative CSF examination. Additionally, we describe the clinicopathological features of patients with proven NL and their clinical course and response to treatment.
MATERIALS AND METHODS

Patients
This is a retrospective series of NL patients diagnosed by NB and PCR-based analysis. Patients with a negative CSF examination and NB-confirmed diagnosis of NL who were seen in 2 neurological departments (Limoges University Hospital and Paris Piti e-Salpêtrière University Hospital, France), between January 2005 and June 2016, were eligible. They included primary NL and secondary NL whose diagnosis was not certain without NB or whose mechanism of neuropathy was unclear. Medical files were reviewed for demographical data, clinical presentation and course, nerve conduction findings, CSF examination, bone marrow aspiration or biopsy, flow cytometry of blood, CSF or bone marrow, 18 F-FDG PET scan, computed tomography scan (CT scan), magnetic resonance imaging (MRI), and treatment schedules.
This study was performed with retrospective data recorded during usual patient care. The study was approved by our local ethics committee (number 234-2017-20) according to French legislation (the Jard e law concerning biomedical research on human subjects, November 2016) and the Helsinki Declaration (1964, amended most recently in 2008) of the World Medical Association. Written consent for NB was obtained from each patient as routinely done in the 2 centers.
Nerve Histology
NB (sural or peroneal, more rarely radial) was performed by trained neurologists for all patients according to standard techniques (13) . The site of biopsy was guided by clinical and/or electrophysiological findings. The nerve was cut into 3 parts: One was embedded in paraffin for hematoxylin and eosin (H&E) staining and immunolabeling; the second was embedded in Epon and cut into transverse semithin (1 mm) sections, stained with toluidine blue for nerve fiber examination on optical microscope, and ultrathin sections (90 nm), stained with lead citrate and uranyl acetate for electron microscopic analysis. The last part was frozen for further examination, including H&E staining and molecular biology. Immunohistochemical examination was performed with a panel of antibodies: AntiCD20 (clone L26, Roche, Basel Switzerland), antiCD3 (monoclonal, 2GV6, Roche), antiCD68 (clone PGM1, Dako, Glostrup, Denmark), antiCD10 (clone SP67, Roche), antiBcl2 (clone 124, Roche), antiBcl6 (clone GI191E/A8, Roche), antiCD4 (clone SP35, Roche), antiCD8 (clone SP57, Roche), antiCD5 (clone SP19, Riche), antiCD23 (clone 1B12, Leica, Wetzlar, Germany), antiCD79a (clone SP18, Riche), antiCyclineD1 (clone SP4, Roche), proliferation index Ki-67 (clone 30-9, Roche), anti-MUM1 (clone MUM1P, Dako), antikappa chain (rabbit polyclonal, Roche), antilambda chain (rabbit polyclonal, Roche). Analysis of the slides for H&E staining and immunohistochemistry was performed blindly by 2 pathologists (M.D., M.D.C.) using an optical microscope (Leica DM 2500 LED). Quantification of nerve fibers was performed on semithin sections using a published methodology (14) . Slides were scanned with a NanoZoomer 2.ORS and NanoZoomer Digital Pathology 2.5 software was used for image acquisition. Ultrathin sections were observed using a JEOL 1011 electron microscope.
Clonality Testing
After verifying the presence of cell infiltrates in frozen sections, DNA was extracted and purified using a QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) from half of the frozen samples that averaged 0.5-1 cm in length. After DNA extraction, PCR was performed using BIOMED-2 protocol as described (15) . Briefly we realized a multiplex PCR using sense FR1, IGVK, and IGVL gene family-specific primers with an antisense consensus IGJ (JH, JK, or JL) in independent reactions. Polyclonal and monoclonal controls were included for each experiment. Custom-designed primers were used for PCR analysis for samples studied before 2011 in one center (Salpêtrière, Paris). Following amplification, the Ig/TCR PCR products were processed by Genescanning using automatic 3100 DNA sequencer (Applied Biosystems, Foster City, CA) or by heteroduplex analysis with nondenaturing polyacrylamide gel electrophoresis.
Frozen nerve samples from additional patients who underwent NB with a final diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), vasculitis, or paraneoplastic syndrome were used as controls to assess the performance of clonality testing. Only samples with significant cell infiltrates were used.
Statistics
Statistical analysis was performed using GraphPad Prism 6 software. Results are presented as the mean (6 standard deviation) and the median (minimum; maximum), and frequencies are expressed in percentage. Performance of the clonality testing was calculated using all NL cases and the 22 control cases.
RESULTS
Clinical Characteristics
The main results are summarized in Table 1. Among the  1625 nerve biopsies performed in the 2 centers between 2005  and 2016, 15 patients (11 male) were included, with a median age at examination of 67 [48; 91] years. The median interval between onset of neuropathy and NB was 7.1 [1; 52] months.
Hematological malignancies were B-cell hematologic malignancies in all patients but one, who had a T-cell lymphoma. Six patients had secondary NL with a hematological malignancy (Table 1) , classified according to the WHO classification (16) , with a median interval between the diagnosis of hemopathy and onset of neurological symptoms of 7.9 [0; 44] months. The diagnosis of hemopathy was concomitant with that of neuropathy for 1 case (case 8) and 53.3% of patients had a monoclonal gammopathy, including 3 without a known hematological malignancy (Table 2) .
Six patients (40%) had a phenotype of distal axonal polyneuropathy, 5 (33.3%) had a mononeuritis multiplex or multiple root involvement presentation, and the last 4 (26.7%) had a demyelinating neuropathy (with acute onset in case 10). Overall, 8 patients (53.3%) presented an acute/subacute onset. Pain was a prominent feature of neuropathy in 12 patients (80%; Table 2 ).
General Neuropathological Findings
All samples revealed an abnormal infiltrate of mononuclear cells, with a perivascular disposition in 13 cases (86.7%), localized in the epineurium in all cases except one (93.3%), associated with endoneural invasion in 8 cases (53.3%), and perineural invasion in 12 (80%) ( Table 3) . Vasculitis of medium arteries with fibrinoid necrosis was observed in 3 cases (cases 1, 5 and 14) . Two cases showed granulomas (cases 5 and 13).
Hematological malignancy was strongly suspected on histological features (H&E staining) in 11 cases only (73.3%; Table 2 ), based on cytomorphological (i.e. cell maturation, morphometric features) and histomorphological features (i.e. tissue architecture, growth pattern, presence or absence of necrosis and fibrosis, and frequency of mitotic figures) of cells infiltrates. Four (66.7%) of the 6 patients with a history of hematological malignancy had a suspicious infiltrate defined by at least one of the above features (cases [5] [6] [7] [8] .
Because of the size of the biopsy samples and the small inflammatory infiltrate in most cases, all of the immunolabeling studies could not be performed because in some cases there was no longer any available material. All B-cell lymphomas had mostly CD20 þ cells, associated with a strong CD3 þ infiltrate in 9 of 14 cases (64.3%). The diagnosis and characterization of hemopathy based on histology and immunohistochemistry were possible for 6 (cases 6, 7, 8, 13 [ Fig. 1], 14, and 15) , i.e. 40% of all cases, including 3 patients with secondary NL (cases 6-8).
Axonal loss was variable: 8 patients (53.3%) had severe axonal loss, 5 (33.3%) had moderate axonal loss, and 2 (13.3%) had only slight axonal loss. Three patients (20%) showed acute axonal lesions consisting in myelin ovoids, 3 (20%) had demyelinating-remyelinating features (concordant with nerve conduction studies), and 3 (20%) presented both axonal and demyelinating-remyelinating lesions.
Clonality Results
Neurolymphomatosis Group
Search for clonality was realized in all the cases, even when infiltrates of mononuclear cells were not frankly suspicious (cases 3, 4, 10, and 11) because of the context (i.e. known hematologic malignancy for cases 4 and 11) and because acute axonal lesions were present on semithin sections (cases 3, 10, and 11), requiring exclusion of vasculitis or lymphoma ( Table 4 ). The cell infiltrate was monoclonal in 13 cases (86.7%): 12 monoclonal B-cell amplifications and 1 monoclonal T-cell amplification ( Table 2) . Two of these 13 samples had a polyclonal background (cases 3 and 11), with infiltrates that did not appear particularly suspicious on histology. One case (case 10) showed minor monoclonal B-cell clonality results and the search for clonality was inconclusive in 1 case (case 8).
Control Group (Supplementary Data)
We searched for clonality in the 22 control nerve samples from 9 patients with CIDP, 12 with vasculitis, and one with paraneoplastic syndrome associated with antiMa2 antibodies. Only 1 case (4.5%) demonstrated clear clonality for FR1, FR2, and FR3 IgH in the context of cryoglobulinemic vasculitis associated with hepatitis C virus infection. Four cases (18.2%) had a minor monoclonal population that consisted of low-intensity and suspicious peaks. PCR showed an oligoclonal or polyclonal result in 10 cases (45.4%) and in 4 cases (18.2%) there was no amplification. Finally, 3 failed cases corresponded to samples for which the DNA was judged of too poor quality to be amplified.
Correlation between Light Microscopy and Clonality Results
Among the 6 cases where diagnosis and characterization of hemopathy were possible based on histology and immunohistochemistry (cases 6, 7, 8, 13, 14, and 15), clonality was (Fig. 2B ) and this patient was investigated for painful mononeuropathy. NB findings suggested the diagnosis of primary NL but the infiltrate was small and associated with a lot of inflammatory CD3 þ cells. Several weeks later, the patient presented with an increase in size of his left testicle, leading to the diagnosis of lymphoma on orchidectomy. The search for clonality was inconclusive in one of these cases: Case 8 (known chronic lymphoid leukemia [CLL] ). In the absence of PCR amplification, diagnosis of NL was retained on neuropathological features and immunophenotyping (Fig. 2C) .
Among the 5 cases that had a suspicious infiltrate, which did not allow characterization of the hemopathy (cases 1, 2, 5, 9 [ Fig. 2D], and 12 ), all had a monoclonal B result on clonality analysis. In these cases, clonality led to the final diagnosis.
Four cases had no clear evidence of malignant cells on NB (cases 3, 4, 10, and 11), 2 of which had a history of hematologic malignancy (cases 4 and 11). Infiltrate was composed of both CD20þ and CD3þ lymphocytes for cases 3 (Fig. 2E ) and 11 without evidence of malignancy. In these 2 cases, diagnosis of NL was based on clonality results showing a monoclonal result with a polyclonal background. Case 10 displayed a preponderance of CD3 þ / CD5 þ cells relative to CD20 þ cells associated with severe axonal loss and demyelinating lesions. Clonality was not contributive. Diagnosis of lymphoma (Waldenström's macroglobulinemia) was made on lymph node biopsy analysis in this patient. Finally, diagnosis of NL in case 4, in which infiltrate was very slightly suspicious on H&E but immunophenotypic analysis was not possible, was retained based on clonality results (B monoclonal). Moreover, case 4 is also an example of the usefulness of electron microscopy. Indeed, this female patient had been diagnosed with demyelinating neuropathy associated with an IgM monoclonal gammopathy. We found in her nerve sample a small cell infiltrate associated with axonal loss and demyelinating lesions on semithin sections. Electron microscopic examination showed a widening of the outer lamellae of the myelin sheath (Fig. 3) , providing additional information on the mechanism of nerve injury. 
Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV) of Clonality
The performance of clonality results was assessed, considering the final diagnosis of NL as the gold standard, taking into account the history, clinical and laboratory findings. Only monoclonal B or monoclonal T were considered as positive clonality results. Minor monoclonality, polyclonality, or oligoclonality were considered negative clonality results. Case 10 and the 4 control cases with minor monoclonal results and Suspicious but too small infiltrate to make the final diagnosis on histology. In this case, demonstration of clonality led to the final diagnosis. (E) Case 3. Unknown high-grade B-cell lymphoma, not otherwise specified with B monoclonality and polyclonal background. In this case, discreetly suspicious histology and abnormal clonality led to the final diagnosis of infiltrate of lymphoid cells. the 10 control cases with oligoclonal or polyclonal results were considered negative for clonality. We excluded the 3 control cases in which DNA was judged of too poor quality to be amplified. After these considerations, the PPV was 92.9%, NPV was 90%, sensitivity was 86.7%, and the specificity was 94.7%. Overall, the PCR method was not successful in 3 of 37 cases (8.1%).
CSF Examination, 18 F-FDG-PET Scan and MRI Results
Lumbar puncture was performed on 13/15 patients (86.7%) and showed elevated CSF protein content for 61.5%, with a median protein level of 0.60 [0; 7.01] g/L, and hypercellularity for 38.5% (Table 5 ). The diagnosis of NL could not be confirmed by CSF analysis. Only 1 of 6 patients (case 11) had an abnormal 18 F-FDG-PET scan, with hyper-metabolism of the left S1 root, coinciding in MRI with thickening and contrast enhancement of this root extending to the sciatic nerve. The MRI of case 10 (acute inflammatory demyelinating neuropathy) showed bilateral thickening of the lumbar plexus. Finally, MRI of case 14 presented thoracic myelitis and ischemic cerebral lesions.
Diagnostic Tools of Hematological Malignancy in Primary NL
Flow cytometry on blood cells detected abnormalities in 50% of cases (Table 5 ). The diagnosis of lymphoma was made in 3 out of 7 patients who had bone marrow biopsy or aspirate (42.9%; cases 1, 2, and 12). A deep tumor mass was found in 4 of 8 patients (50%) by body CT scan (cases 1, 2, 10, and 12), associated with hyper-metabolism by 18 F-FDG-PET scan (cases 10 and 12). In 1 case (case 14), diagnosis of lymphoma was made on orchidectomy.
Treatment and Evolution
Five patients received immunomodulatory therapy (immunoglobulin or corticosteroids) before NL diagnosis without improvement ( Table 6 ). The patient with T-cell lymphoma was treated with chlorambucil alone due to his advanced age. Patients with B-cell lymphomas were treated with various chemotherapy regimens, except for 2 cases for which corticosteroids alone were administered (leading to short-term clinical stabilization for case 3 and no improvement for case 5), with their subsequent deaths. Chemotherapy resulted in a good hematological response for case 10 (acute inflammatory demyelinating polyneuropathy), whereas the neuropathy chronically worsened despite the resume of immunoglobulin, but the patient died shortly after the second course.
Median survival was 19 [3; 93] months. Long-term survival and improvement were observed only for the 2 patients with NL linked to CLL (disappearance of dysautonomia for patient 4 and partial regression of pain for patient 8). Two patients diagnosed with DLBCL had a neurological and hematological stabilization under R-CHOP protocol (in association with intrathecal cytarabine injections for case 11). There was mild improvement of upper-limb sensory involvement and weakness for case 14 (intravascular large B-cell lymphoma), without neurological recovery of the lower limbs. Progression of the disease led to death in 8 cases despite neurological stabilization in case 9.
DISCUSSION
Diagnosing NL is very challenging despite the large number of techniques that can lead to this diagnosis, such as CSF examination, bone marrow aspiration or biopsy, flow cytometry of blood, CSF or bone marrow, 18 F-FDG PET scan, CT scan, and MRI. Therefore, NB is sometimes required to confirm the diagnosis of NL. When a NB is performed, the main difficulty resides in distinguishing reactive cell infiltrates from neoplastic lymphoproliferation by histological examination (9) . Moreover, pathological infiltrates are often of small size in nerve samples, further increasing the difficulty of identifying their malignant nature. Here, we present the largest series studying clonality in NL and showing the performance of this technique, which has not been validated in PNS infiltration, despite its use on various tissue samples (17, 18) .
Cr eange et al (11) reported 7 cases of neuromuscular disorders associated with CLL, for which a search for heavychain rearrangements by PCR amplification of the CDRIII region was performed using primers developed by Yamada et al (19) . They showed the presence of a monoclonal population in all cases, including 4 of muscular involvement and 3 of nerve damage. Viala et al reported positive clonality results in 3 of 4 cases of NL in their series of lymphoma-associated neuropathies, the fourth case was diagnosed by routine histological examination alone (12) . These results were compared with clonality studies in the blood or bone marrow, showing the same rearrangements. In another series of neuropathies associated with Waldenström's macroglobulinemia, Viala et al showed nerve infiltration in 2 cases, demonstrated by the presence of immunoglobulin chain rearrangements that were similar in the nerve and bone marrow in 1 case (20) .
The European BIOMED-2 network (now called EuroClonality Consortium) developed and validated standardized multiplex PCR assays for nearly all Ig/TCR targets (18) and published guidelines for interpretation of clonality results (15) . The BIOMED-2 PCR protocols have also been extensively validated in many others studies outside the consortium, providing a standard for detection of clonality in lymphoid malignancies (21) . The optimized primer design provides a reliable detection of clonality in lymphoid malignancies and these multiplex PCR assays have become the world standard for the routine clonality testing.
The search for clonality in nerve samples was conclusive in 86.7% of the NL cases in our study. This rate is slightly lower than that reported for other tissues (18, 22, 23) , but the difference can be explained by the often low-level infiltrate in nerve samples and the negative CSF examination despite overt clinical manifestations. Moreover, root involvement may be prominent in NL due to the weaker blood-nerve barrier at this level, and NB was always performed distally in our patients. Although targeted fascicular NB has been demonstrated to be useful in NL, it is only realistically feasible at the brachial plexus level and most of our patients had signs that predominated in the lower limbs (24) . Therefore, our results highlight the usefulness of searching for clonality in the diagnosis of NL especially in cases where diagnosis is difficult to make. Indeed, although nerve infiltrates were suspicious in 73.3% of our NL cases, histological confirmation and characterization of NL was possible for only 40% of them, including 3 patients with known hematological malignancy. When the infiltrate of mononuclear cells is not suspicious (based on cytomorphologic features) or massive, one must be wary if acute axonal lesions are present on semithin sections as in cases 3, 10, and 11, even if there is no known hematologic malignancy (cases 3 and 10). Indeed, despite a polyclonal background for cases 3 and 11, the diagnosis of NL could be made based on clonality results on the NB sample. Moreover, when there is strong suspicion, it is essential to carry out a complete assessment so as not to ignore a NL, as demonstrated in case 10 in which the diagnosis could be made on analysis of lymph node clonality despite an inconclusive result on NB.
Hematological malignancy may coexist with an immune-mediated neuropathy, as exemplified in our case 4 where a thorough examination of a nerve sample (optical microscopy, electron microscopy, molecular biology) led to the diagnosis of NL (suspicious infiltrate on NB, monoclonal B result with PCR analysis) and widening of myelin lamellae secondary to the deposition of IgM with antiMAG activity (Fig. 3) . Electron microscopy analysis thus allowed us to understand the lesional mechanism of nerve damage.
One of the strengths of our study is the presence of a control group composed of patients with significant nerve infiltrates in nerve samples given that any laboratory exam may have its false negative and false positive results. The control group helped in demonstrating the good PPV and NPV of the technique, which is of paramount importance for a disorder in which highly active treatment is necessary. Four control cases and 2 NL cases in our series showed a minor monoclonal population; however, the peaks were small or doubtful and were detected in a polyclonal background or in only a single tube. These results can be explained for the NL cases by small cell infiltrates in the nerve coexisting with a strong inflammatory response composed of T cells, making the histological analysis also difficult. Moreover, nontumoral infiltrates in small quantities may appear to be "pseudoclonal" after amplification (25) . Langerak et al tested the BIOMED-2 primers in histologically defined reactive lesions and found this pseudoclonal character in 15% of cases, in particular for T cells, which they thought were "probably polyclonal" (26) . Nevertheless, these reactive "pseudoclonal" infiltrates may be associated with tumor cells and mask them, as illustrated in case 5, in which large granulomas and lesions of necrotizing vasculitis were observed, increasing the diagnostic challenge. In this case there was no immunophenotypic argument to retain the diagnosis of lymphoma, even if the infiltrates were mainly composed of B cells: The search for clonality was then decisive. In contrast, this search did not prove the malignant nature of the infiltrate in all our cases. Case 8 (CLL) did not show amplification, although the extracted DNA was of good quality. The multifocal distribution and small size of the infiltrates may explain this failure. This study has several limitations. The first limitation is the retrospective nature of this work, although clinical and laboratory data were carefully recorded at the time patients were seen and investigated for their PNS disease. Second, the sets of primers that were used for PCR amplification were not exactly the same for all patients due to the presence of relatively old cases that were examined before consensual standard primers had been designed. Third, as it is a bicentric study, investigations that were performed in the diagnostic workup of NL had not been standardized, explaining some differences in the use of morphologic and functional imaging. Finally, for technical limitations no patient had imaging-guided proximal nerve or plexus surgical biopsy.
In addition to the systematic description of the clonality results of this series, we provide the neuropathological description of the NL cases. The pattern was predominantly that of perivascular epineural infiltration without necrosis, which sometimes diffused into the endoneurium, where it was often arranged along the nerve fibers. These results are consistent with numerous histological descriptions of NL (5, (27) (28) (29) (30) . The resulting nerve lesions are generally axonal or mixed (5, 27, 29) , concordant with the observations in our study. Nevertheless, 2 patients showed necrotizing vasculitis, which is less frequent, but has already been described in the setting of lymphoma (31) . Two others showed granulomas, which have also already been described (11) . Only 4 patients had DLBCL, which is lower than the expected frequency (2), and no patient had follicular lymphoma. However, these histological types may be overrepresented in the literature, given the predominant use of histology alone for the identification of lymphomatous cells in most of the reported cases. Moreover, the restriction of the present study to cases diagnosed by NB led to a selection bias, eliminating cases in which the study of CSF contributes to the diagnosis, potentially explaining the difference between our study and previous studies. The clinical and electrodiagnostic features found here were that of a mostly painful, length-dependent, sensory-motor neuropathy, with a subacute or chronic course, consistent with previous descriptions (3). Finally, the involvement of PNS by intravascular lymphoma has been described but remains rare, especially when it is confined to PNS locations (0.01%) (32) .
Mechanisms leading to PNS invasion by cells from a hematological malignancy are likely diverse. Lymphomatous cells retain their physiological lymphocyte migration and recirculation properties, as observed for other types of extranodal dissemination of systemic lymphomas (33) . Some adhesion molecules and chemokine receptors have been associated with various types of lymphomas and different sites of spread but have not been specifically identified in NL. Other rare cases of lymphoma appear to be restricted to the PNS. Kuntzer et al reported a mononeuropathy multiplex pattern that reached the cranial nerves and gradually spread to the 4 limbs (34) . Autopsy findings were consistent with mainly endoneural infiltration of the nerves. The interest of this case was the apparent absence of systemic involvement outside the PNS and the presence of very clear delimitation at the peripheral myelin/central myelin junction, the latter without infiltration, reflecting a probable entity restricted to the PNS.
The median survival of patients with NL in our series was 19 months, which is slightly longer than in previously reported studies. Grisariu et al reported global median survival of 10 months, and in subgroup analysis, a median of 20 months for primary NL versus 8 months for secondary NL (1). Kamiya-Matsuoka et al reported a median survival of 15 months in their series of 6 patients (35) . Survival and response to treatment were much better for CLL than for other types of lymphoma.
Waldenström's macroglobulinemia is an important cause of neuropathy, with a broad spectrum of effects (e.g. antiMAG and amyloidosis) (36) , including PNS infiltration (20) . The MYD88 (L265P) mutation was identified in blood samples from >90% of patients with this lymphoproliferative disease (37) . We found this mutation in the DNA extracted from the nerve fragment of 1 patient (case 7, data not showed), providing an additional argument in favor of lymphomatous infiltration.
There was only a weak contribution of 18 F-FDG-PET scan (16.7% among those who had the examination) in the diagnosis of NL, whereas the reported sensitivity of 18 F-FDG-PET scan in NL is 88% (1) . Moreover, other studies have also shown a better contribution of this examination to the diagnosis of NL, even if it only allows diagnostic suspicion (38) (39) (40) . The analysis of our cohort may be biased because only 6 of 15 patients in our study underwent a 18 F-FDG-PET scan. These considerations may also be valid concerning MRI, which was only performed for 5 of 15 cases, and positive for only 60%, whereas the reported sensitivity is 77% (1). These 2 examinations, used concomitantly, provide useful information for the diagnosis of NL, especially in difficult cases, as emphasized in a recent study (41) .
Conclusion
In conclusion, this study confirms the diagnostic challenge of NL (despite current powerful diagnostic tools) because of varying clinical presentations caused by various malignancies and with different mechanisms of neuropathy. It also highlights the utility of NB but underlines that the low level of infiltrates in nerve biopsies may be an additional difficulty. Finally, this study illustrates the high efficiency of PCRbased clonality testing to assess the malignant nature of PNS lymphoid infiltration, whether to prove the monoclonality of a weak infiltrate of the biopsy or to help differentiate a malignant infiltrate from an inflammatory reaction, especially when the 2 are entangled.
